Which addictions use MAT?

Medication-assisted treatment is most commonly used for opioid use disorder and alcohol use disorder because these conditions involve significant neurological adaptation, withdrawal instability, craving intensity, and elevated relapse or overdose risk. Medications used in MAT are designed to affect addiction-related brain pathways involved in reward processing, stress regulation, physical dependence, and compulsive substance-seeking behavior. Different medications are used depending on the substance involved and the underlying neurobiology of the addiction.

Opioid use disorder commonly involves medications such as methadone, buprenorphine-based medications including Suboxone, and naltrexone. Methadone and buprenorphine activate opioid receptors in controlled ways that reduce withdrawal symptoms and cravings, while naltrexone blocks opioid receptors and reduces reinforcing opioid effects. These medications are widely used within evidence-based opioid addiction treatment frameworks.

Alcohol use disorder may involve medications such as naltrexone, acamprosate, and disulfiram. These medications affect craving intensity, alcohol reward pathways, or physiological reactions to alcohol consumption through different mechanisms. Medication selection may depend on alcohol use severity, medical conditions, psychiatric symptoms, and overall treatment goals.

MAT is less commonly used for stimulant use disorders involving cocaine or methamphetamine because no FDA-approved medications currently exist specifically targeting stimulant addiction in the same way opioid or alcohol medications do. Research continues examining medications that may affect stimulant cravings, impulsivity, or reward circuitry. Behavioral and psychological interventions remain central components of stimulant addiction treatment.

The use of MAT depends on the substance involved, medical safety concerns, relapse vulnerability, psychiatric symptoms, overdose risk, and neurological effects of the addiction. Medications used in addiction treatment are generally viewed as tools that support stabilization, withdrawal management, and relapse reduction through targeted pharmacological mechanisms. MAT is therefore primarily associated with opioid and alcohol use disorders.